TFSL insider plans Rule 144 sale of 12,911 shares

TFSL insider Meredith Weil has filed a notice to sell 12,911 shares of common stock under Rule 144.

Accepted by SEC EDGAR 02/11/2026 - 05:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TFSL insider Meredith Weil has filed a notice to sell 12,911 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney on NASDAQ around 02/11/2026, with an aggregate market value of $192,987.17, versus 280,570,799 shares outstanding.

In the past three months, Meredith Weil also sold common shares in two transactions: 2,089 shares for $31,606.00 on 02/10/2026 and 15,000 shares for $207,750.00 on 11/12/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TFSL Form 144 filing disclose about planned share sales?

The filing shows a plan to sell 12,911 shares of TFSL common stock under Rule 144. These shares have an aggregate market value of $192,987.17 and are expected to be sold on NASDAQ around February 11, 2026.

Who is selling TFSL shares in this Form 144 and through which broker?

The Form 144 lists Meredith Weil as the seller of TFSL common shares. The planned sale of 12,911 shares will be executed through Morgan Stanley Smith Barney LLC, using its Executive Financial Services unit at New York Plaza as the broker.

How many TFSL shares are outstanding compared to the Form 144 sale size?

The filing states 280,570,799 TFSL common shares outstanding, while the planned Rule 144 sale covers 12,911 shares. This highlights that the intended sale represents a very small fraction of the issuer’s total common shares outstanding at the stated time.

What recent TFSL stock sales by Meredith Weil are disclosed in the Form 144?

The document reports two prior TFSL common stock sales in the last three months by Meredith Weil: 2,089 shares sold on 02/10/2026 for $31,606.00, and 15,000 shares sold on 11/12/2025 for $207,750.00 in gross proceeds.

How were the TFSL shares being sold under Form 144 originally acquired?

The filing shows the TFSL common shares were acquired from the issuer as restricted stock and performance shares on 12/10/2022 and as additional restricted stock on 12/10/2024. The nature of payment is listed as Not Applicable for these awards.

On what exchange will the TFSL Form 144 shares be sold and when?

The seller plans to dispose of 12,911 TFSL common shares on the NASDAQ exchange. The approximate date of sale disclosed is 02/11/2026, indicating when the brokered transactions are expected to occur, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001530997
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TFS FINANCIAL CORPORATION
SEC File Number	001-33390
Address of Issuer	7007 Broadway Avenue Cleveland OHIO 44105
Phone	(216) 441-6000
Name of Person for Whose Account the Securities are To Be Sold	MEREDITH S. WEIL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12911	192987.17	280570799	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2022	Restricted Stock	Issuer			4917	12/10/2022	Not Applicable
Common	12/10/2022	Performance Shares	Issuer			7439	12/10/2022	Not Applicable
Common	12/10/2024	Restricted Stock	Issuer			555	12/10/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Meredith Weil 7007 Broadway Avenue Cleveland OH 44105	Common	02/10/2026	2089	31606.00
Meredith Weil 7007 Broadway Avenue Cleveland OH 44105	Common	11/12/2025	15000	207750.00

144: Remarks and Signature

Remarks
Date of Notice	02/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Meredith S Weil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)